Ephrin Receptor A5 Blocking Peptide peptide (STJ504013)

SPECIFICATIONS
ImmunogenSynthetic peptide taken within amino acid region 600-700 on human EphA R5 protein.
STJ504013-250
🚚 Free UK Delivery on orders over £150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionEphrin Receptor A5 Blocking Peptide is synthetically produced from the 600-700 sequence and is suitable for use in western blot applications.
ApplicationsImmunodepletion/Immunocompetition
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

FormulationLiquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice.
Storage InstructionStore at-20°C for long term storage. Avoid freeze-thaw cycles.

Target Information

Gene SymbolEPHA5
Gene ID2044
Uniprot IDEPHA5_HUMAN
ImmunogenSynthetic peptide taken within amino acid region 600-700 on human EphA R5 protein.
Immunogen Region600-700

Additional Info

Tissue Specificity Almost exclusively expressed in the nervous system in cortical neurons, cerebellar Purkinje cells and pyramidal neurons within the cortex and hippocampus. Display an increasing gradient of expression from the forebrain to hindbrain and spinal cord.
Post Translational Modifications Phosphorylated. Phosphorylation is stimulated by the ligand EFNA5. Dephosphorylation upon stimulation by glucose, inhibits EPHA5 forward signaling and results in insulin secretion.
Function Receptor tyrosine kinase which binds promiscuously GPI-anchored ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Among GPI-anchored ephrin-A ligands, EFNA5 most probably constitutes the cognate/functional ligand for EPHA5. Functions as an axon guidance molecule during development and may be involved in the development of the retinotectal, entorhino-hippocampal and hippocamposeptal pathways. Together with EFNA5 plays also a role in synaptic plasticity in adult brain through regulation of synaptogenesis. In addition to its function in the nervous system, the interaction of EPHA5 with EFNA5 mediates communication between pancreatic islet cells to regulate glucose-stimulated insulin secretion.
Peptide Name Ephrin Type-A Receptor 5
Brain-Specific Kinase
Eph Homology Kinase 1
Ehk-1
Eph-Like Kinase 7
Ek7
Hek7
Database Links Reactome: R-HSA-2682334
Reactome: R-HSA-3928663
Reactome: R-HSA-3928665
Cellular Localisation Cell Membrane
Single-Pass Type I Membrane Protein
Cell Projection
Axon
Dendrite
Alternative Peptide Names Ephrin Type-A Receptor 5 protein
Brain-Specific Kinase protein
Eph Homology Kinase 1 protein
Ehk-1 protein
Eph-Like Kinase 7 protein
Ek7 protein
Hek7 protein
EPHA5 protein
BSK protein
EHK1 protein
HEK7 protein
TYRO4 protein

Information sourced from Uniprot.org

Citations

Product Review

Well-cited Academic Publications
KO-Validated 700+ Lines
Technical Support Expert Scientific Team
1-Year Guarantee Antibodies & Proteins